Lancaster University in collaboration with AstraZeneca offers a CASE PhD Studentship starting October 2027 in the Chemistry Department. The project focuses on developing selective PDE4B-targeting PROTACs to modulate inflammation and improve animal health, with training in medicinal chemistry, chemical biology and drug discovery.
This fully funded project includes an industrial collaboration with AstraZeneca and a 3-month placement at AstraZeneca, providing hands-on experience and exposure to
#J-18808-Ljbffr
